全文获取类型
收费全文 | 35499篇 |
免费 | 2945篇 |
国内免费 | 1436篇 |
专业分类
耳鼻咽喉 | 452篇 |
儿科学 | 621篇 |
妇产科学 | 612篇 |
基础医学 | 4228篇 |
口腔科学 | 608篇 |
临床医学 | 3941篇 |
内科学 | 5671篇 |
皮肤病学 | 798篇 |
神经病学 | 2266篇 |
特种医学 | 1198篇 |
外国民族医学 | 13篇 |
外科学 | 4331篇 |
综合类 | 4832篇 |
现状与发展 | 6篇 |
一般理论 | 20篇 |
预防医学 | 2077篇 |
眼科学 | 1198篇 |
药学 | 2977篇 |
29篇 | |
中国医学 | 1332篇 |
肿瘤学 | 2670篇 |
出版年
2024年 | 47篇 |
2023年 | 429篇 |
2022年 | 682篇 |
2021年 | 1638篇 |
2020年 | 1226篇 |
2019年 | 1054篇 |
2018年 | 1188篇 |
2017年 | 1092篇 |
2016年 | 1049篇 |
2015年 | 1437篇 |
2014年 | 1814篇 |
2013年 | 1712篇 |
2012年 | 2583篇 |
2011年 | 2604篇 |
2010年 | 1529篇 |
2009年 | 1320篇 |
2008年 | 1869篇 |
2007年 | 1912篇 |
2006年 | 1883篇 |
2005年 | 1861篇 |
2004年 | 1337篇 |
2003年 | 1126篇 |
2002年 | 1057篇 |
2001年 | 862篇 |
2000年 | 867篇 |
1999年 | 851篇 |
1998年 | 499篇 |
1997年 | 407篇 |
1996年 | 310篇 |
1995年 | 318篇 |
1994年 | 252篇 |
1993年 | 182篇 |
1992年 | 319篇 |
1991年 | 292篇 |
1990年 | 285篇 |
1989年 | 256篇 |
1988年 | 219篇 |
1987年 | 202篇 |
1986年 | 201篇 |
1985年 | 150篇 |
1984年 | 107篇 |
1983年 | 72篇 |
1982年 | 45篇 |
1981年 | 50篇 |
1979年 | 72篇 |
1978年 | 51篇 |
1977年 | 51篇 |
1974年 | 65篇 |
1973年 | 60篇 |
1972年 | 63篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
81.
蜂毒素微球经动脉介入治疗大鼠肝癌的实验研究 总被引:9,自引:0,他引:9
目的:观察蜂毒素微球(M-MS)经动脉介入对大鼠肝癌的治疗作用.方法:采用改良的复乳-液中干燥法制备蜂毒素-聚乳酸/羟乙酸微球,建立大鼠移植性肝癌模型并随机分为四组,分别经肝动脉灌注生理盐水(NS,1.5ml/kg)、蜂毒素(Melittin,0.35mg/kg)、空白微球(B-MS,10mg/kg)和蜂毒素-聚乳酸/羟乙酸微球(10mg/kg).比较治疗后各组大鼠的肿瘤生长情况、肿瘤坏死程度和生存时间.结果:与生理盐水组比较,Melittin组、B-MS组肿瘤生长受到明显抑制(P<0.01),肿瘤坏死程度以轻中度为主,但两组动物生存时间均未能明显延长(P>0.05).M-MS组与NS组、Melittin组及B-MS组相比,肿瘤生长抑制显著(P<0.01),肿瘤坏死更广泛、更彻底,且经蜂毒素微球治疗的大鼠生存期显著延长(P<0.01).结论:蜂毒素以药物微球的剂型经肝动脉给药,抗肿瘤效果明显优于单纯的蜂毒素和空白微球. 相似文献
82.
消化道手术中医源性脾损伤的预防和处理 总被引:10,自引:0,他引:10
医源性脾损伤(iatrogenicsplenicinjury)通常是指处理脾脏邻近器官的手术时,由于手术操作、医疗器械使用不当或局部解剖变异所造成的脾脏损伤。在临床上因各种原因导致的医源性脾损伤并不罕见,而且一旦发生损伤将会引发手术时间延长、术中失血量增加、病人住院时间延长等一系列问题;有的尚须行无辜性脾切除,导致脾切除术后发生并发症的风险增加,不仅给病人带来痛苦,甚至危及其生命。因此,医源性脾损伤已成为外科领域值得关注的问题。1应尽力避免医源性脾损伤消化道手术中医源性脾损伤的发病情况国内外报道不尽相同。Cassar等[1]报告,近40%… 相似文献
83.
分步骤法维护三向瓣膜式PICC导管留置效果观察 总被引:5,自引:2,他引:3
目的预防外周中心静脉导管置管(PICC)后滑脱及体外部分非人为移入体内,减少局部炎症反应,防止导管性静脉炎发生.方法将42例接受PICC的肿瘤化疗患者随机分为观察组(n=22)和对照组(n=20),观察组采用分步骤法维护,即分步骤地更换透明贴膜及肝素帽(或先换肝素帽,再换透明贴膜),并将导管体外部分直形固定;对照组采用传统法维护,即同时更换透明贴膜及肝素帽,导管体外部分S形固定.结果观察组静脉炎,穿刺点渗液、硬结,导管移位发生率显著低于对照组(P<0.05,P<0.01).结论行PICC导管维护时,分步骤更换透明贴膜及肝素帽,将导管体外部分直形固定,可有效防止导管滑脱及体外部分进出体内,减少局部炎症反应,预防导管性静脉炎. 相似文献
84.
85.
本文报道给家兔注入不同剂量的~3H-α-第二丁基对羟基苄醇,观察该药在其体内的药物动力学。结果表明,血中分布相快,消除相慢,消除半衰期T_1/1β为12h。经F值检验和理论计算值与实测值的契合程度比较,表明该药在兔体内的运转符合二室开放模型的动力学方程。 相似文献
86.
In view of the ability of ketones to partially replace glucose as an alternative fuel in the brain, the potential protective effects of diet-induced ketosis were examined in male NEDH rats with hypoglycaemia due to a serially transplantable radiation-induced insulinoma. Ketosis was induced by daily oral administration of medium chain triglycerides to normal rats and to insulinoma-bearing rats 1 day after subcutaneous subscapular implantation of tumours fragments. All rats treated with medium chain triglycerides became ketotic within 72 hours, and plasma 3-hydroxybutyrate concentrations remained 5-10 fold elevated at 24 days. Untreated insulinoma-bearing rats became moderately hyperinsuliaemic and hypoglycaemic by 17 days, with the later manifestation of more marked hyperinsulineamia (21.6 +/- 0.8 ng/ml, mean +/- SEM) severe hypoglycaemia (1.5 +/- 0.1 mmol/l) and death by 24-28 (26 +/- 1) days. Induction and maintenance of hyperketonaemia did not affect the development of hyperinsulineamia, hypoglycaemia or the exaggerated fall of plasma glucose produced by an 8 hour fast in these rats. However by day 21, the severity of hypoglycaemia was greater in insulinoma-bearing rats receiving medium chain triglycerides, culminating in accelerated death by 22-25 (23 +/- 1) days and an accompanying 50% decrease in final tumour weight. These results demonstrate that induction of ketosis in the face of marked hyperinsulinaemia did not afford protection against the profound hypoglycaemia produced by a serially transplantable rat insulinoma. 相似文献
87.
88.
Performance standards for toric soft contact lenses. 总被引:1,自引:0,他引:1
Jacqueline Tan Eric Papas Nicole Carnt Isabelle Jalbert Cheryl Skotnitsky Maki Shiobara Edward Lum Brien Holden 《Optometry and vision science》2007,84(5):422-428
PURPOSE: To simplify the clinical assessment of toric soft contact lens (TSCL) on-eye behavior by establishing a set of standard clinical evaluation techniques. The likely performance range expected among the TSCL wearing population was determined for a series of lens designs and acceptable performance standards indicated for each variable. METHODS: Four prism-ballast, two peri-ballast and one dynamic stabilization TSCL designs were each worn by groups of 20 subjects in a nondispensing study. After 20 min of lens wear, lenses were assessed, in right eyes only, for subjective comfort (100-point scale), lens mislocation (degrees deviation from vertical) and rotational recovery after deliberate 30 degrees mislocation (degrees/10 blinks). The percentage of lenses orienting within +/-10 degrees of target orientation (zero rotation) and the variability of orientation (standard deviation of mislocation) were also calculated for each lens group. RESULTS: Based on partitioning of the data distributions for each variable, performance was designated as excellent, acceptable or poor. Corresponding performance cut-offs were determined at > or =90, 89 to 80, and <80 for subjective comfort, < or =+/-6 degrees , +/-7 degrees to 10 degrees , and >+/-10 degrees for mislocation, >10 degrees /10 blinks, 10 degrees to 6 degrees /10 blinks, and <6 degrees /10 blinks for rotational recovery. For groups of wearers the appropriate cut-offs were > or =90%, 89 to 70%, and <70% of lenses orienting within +/-10 degrees of target orientation and <+/-6 degrees , +/-6 degrees to 10 degrees , and >+/-10 degrees for variability of orientation. CONCLUSION: Techniques suitable for the evaluation of TSCL clinical performance have been described and guidelines for the assessment of such lenses established. In the process, we have identified potential performance differences that may relate to variations in TSCL design. 相似文献
89.
90.
Acute Cellular Rejection with CD20-Positive Lymphoid Clusters in Kidney Transplant Patients Following Lymphocyte Depletion 总被引:1,自引:0,他引:1
L. K. Kayler F. G. Lakkis C. Morgan A. Basu D. Blisard H. P. Tan J. McCauley C. Wu R. Shapiro P. S. Randhawa 《American journal of transplantation》2007,7(4):949-954
Lymphoid clusters (LC) containing CD20-positive B cells in kidney allografts undergoing acute cellular rejection (ACR) have been identified in small studies as a prognostic factor for glucocorticoid resistance and graft loss. Allograft biopsies obtained during the first episode of ACR in 120 recipients were evaluated for LC, immunostained with CD20 antibody, and correlated with conventional histopathologic criteria, response to treatment and outcome. LC were found in 71 (59%) of the 120 biopsies. All contained CD20 positive B cells that accounted for 5-90% of the LC leukocyte content. The incidence of LC was highest in the patients who had no lymphoid depletion or had been treated with Thymoglobulin preconditioning (79% vs. 75%, respectively) compared to 37% in patients pretreated with Campath (p = 0.0001). Banff 1a/1b ACR were more frequent in the LC-positive than the LC-negative group (96% vs. 80%, respectively; p = 0.0051). With a posttransplant follow-up of 953 +/- 430 days, no significant differences were detected between LC-postitive and LC-negative groups in time to ACR, steroid resistance, serum creatinine and graft loss. CD20+LC did not portend glucocorticoid resistance or worse short to medium term outcomes. CD20+LC may represent a heterogenous collection in which there may be a small still to be fully defined unfavorable subgroup. 相似文献